About
Zevra Therapeutics develops and delivers treatments for rare diseases, including Niemann-Pick disease type C, urea cycle disorders, and vascular Ehlers-Danlos syndrome.
Explore Zevra Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.